Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-Adjuvanting Polyguanidine Nanovaccines for Cancer Immunotherapy
Xuanbo Zhang, Kaiyuan Wang, Zhiqiang Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 7136-7147
Closed Access | Times Cited: 17

Showing 17 citing articles:

Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives
Eliana B. Souto, Cristina Blanco-Llamero, Karolline Krambeck, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 1-17
Open Access | Times Cited: 36
Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy
Yuqi Cao, Lu Tang, Cong Fu, et al.
Nano Letters (2024) Vol. 24, Iss. 22, pp. 6767-6777
Closed Access | Times Cited: 17
A pH-Responsive and Guanidinium-Rich Nanoadjuvant Efficiently Delivers STING Agonist for Cancer Immunotherapy
Xiao Juan Lu, Heming Xia, Wei Gao, et al.
ACS Nano (2025)
Closed Access | Times Cited: 2
Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond
Jessica C. Hsu, Peng Liu, Yangmeihui Song, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 15, pp. 7657-7680
Closed Access | Times Cited: 11
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
Lei‐Ming Cao, Yifu Yu, Zi‐Zhan Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Advances in Polymer‐Based Self‐Adjuvanted Nanovaccines
Xiaoli Ling, Ziyan Dong, Jiao He, et al.
Small (2025)
Closed Access | Times Cited: 1
Recent Progress in Cancer Vaccines and Nanovaccines
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 4
Alkyl Chain Engineering of Ionic Aie Molecules for Developing Superior Self-Adjuvanted Nanovaccines in Cancer Immunotherapy
Yijun Chen, Chao Chen, Yanfang Bao, et al.
(2025)
Closed Access
Alkyl chain engineering of ionic AIE molecules for developing superior self-adjuvanted nanovaccines in cancer immunotherapy
Yijun Chen, Yixuan Bao, Yubo Wang, et al.
Chemical Engineering Journal (2025), pp. 159979-159979
Open Access
Functionalized carbon dots with guanidine salt ionic liquid regulate oxidative damage and amyloid aggregation
Chao Wang, Tongtong Hou, Xu Shao, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141531-141531
Closed Access
Improving the Efficacy of Cancer mRNA Vaccines
Ameya R. Kirtane, Giovanni Traverso
The Cancer Journal (2025) Vol. 31, Iss. 2
Closed Access
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
STING pathway activation with cisplatin polyprodrug nanoparticles for chemo-immunotherapy in ovarian cancer
Huijiao Fu, Xiaojing Guo, Fang Feng, et al.
Journal of Controlled Release (2025)
Closed Access
Highly Efficient Thiol-Michael Addition Post-Modification toward Potent Degradable Antibacterial Polyesters with Guanidine Moiety
Yilin Qian, Wei Li, Yang Cheng, et al.
Biomacromolecules (2025)
Closed Access
Glycopolypeptide Coordinated Nanovaccine: Fabrication, Characterization, and Antitumor Immune Response
Yingying Song, Lin Teng, Yanzheng Chen, et al.
Chem & Bio Engineering (2024) Vol. 1, Iss. 7, pp. 633-646
Closed Access | Times Cited: 2
Emerging Cationic Nanovaccines
Ana Maria Carmona‐Ribeiro, Yunys Pérez-Betancourt
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1362-1362
Open Access | Times Cited: 1
mRNA vaccines as cancer therapies
Shaoxiong Huang, Haiying Que, Manni Wang, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Application of Albumin in Nanodrugs for Cancer Therapy
Shangshang Li, Yunxin Xue, Chun Mao, et al.
ChemistrySelect (2024) Vol. 9, Iss. 40
Closed Access
Page 1

Scroll to top